Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos...

Published on 3 May 2024 on Benzinga

Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos...

Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from $(0.59) a year ago, missing the consensus of $(0.57).

The company reported sales of $85.6 million, up 16% Y/Y, beating the consensus of $79.6 million.

Read the rest of the article

NYSE.GKOS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks · via Yahoo Finance 9 Jan 2025

Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?

Shares of Glaukos Corporation GKOS scaled a new 52-week high of $155.76 on Jan. 6, before closing...

Zacks · via Yahoo Finance 7 Jan 2025

Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA

Glaukos Corporation GKOS recently announced that it has submitted its New Drug Application (NDA) ...

Zacks · via Yahoo Finance 24 Dec 2024

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks · via Yahoo Finance 11 Dec 2024

Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?

GKOS stock gains from strong product demand, international expansion and pipeline progress, which...

Zacks · via Yahoo Finance 21 Nov 2024

Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos...

Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from...

Benzinga 3 May 2024

Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y

Glaukos Corporation GKOS reported first-quarter 2024 adjusted loss of 70 cents per share, which i...

Zacks via Yahoo Finance 3 May 2024

Glaukos stock price target raised on strong Q1 sales By Investing.com

On Thursday, Glaukos Corporation (NYSE:GKOS) received an updated stock price target from Needham,...

Investing.com 3 May 2024

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?

The earnings season for the Medical sector (one of the 16 broad Zacks sectors within the Zacks In...

Zacks via Yahoo Finance 1 May 2024

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 15 Apr 2024

News

Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos...

NYSE.GKOS price evolution

Want to become a better investor?